Nava Health MD Statistics
Total Valuation
Nava Health MD has a market cap or net worth of $83.10 million. The enterprise value is $87.39 million.
| Market Cap | 83.10M |
| Enterprise Value | 87.39M |
Important Dates
The last earnings date was Tuesday, October 28, 2025.
| Earnings Date | Oct 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Nava Health MD has 13.85 million shares outstanding.
| Current Share Class | 17.66M |
| Shares Outstanding | 13.85M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 15.78% |
| Owned by Institutions (%) | 52.55% |
| Float | 12.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 22.43 |
| PS Ratio | 8.96 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.43 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | 0.97 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.38 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -60.65% |
| Return on Capital Employed (ROCE) | 4.22% |
| Revenue Per Employee | $132,443 |
| Profits Per Employee | -$14,786 |
| Employee Count | 70 |
| Asset Turnover | 1.01 |
| Inventory Turnover | 3.13 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Nava Health MD had revenue of $9.27 million and -$1.04 million in losses. Loss per share was -$0.07.
| Revenue | 9.27M |
| Gross Profit | 4.86M |
| Operating Income | -1.54M |
| Pretax Income | -1.04M |
| Net Income | -1.04M |
| EBITDA | -866,000 |
| EBIT | -963,000 |
| Loss Per Share | -$0.07 |
Full Income StatementBalance Sheet
The company has $893,000 in cash and $5.18 million in debt, giving a net cash position of -$4.29 million or -$0.31 per share.
| Cash & Cash Equivalents | 893,000 |
| Total Debt | 5.18M |
| Net Cash | -4.29M |
| Net Cash Per Share | -$0.31 |
| Equity (Book Value) | -2.64M |
| Book Value Per Share | -0.19 |
| Working Capital | 102,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$1.75 million and capital expenditures -$20,000, giving a free cash flow of -$1.77 million.
| Operating Cash Flow | -1.75M |
| Capital Expenditures | -20,000 |
| Free Cash Flow | -1.77M |
| FCF Per Share | -$0.13 |
Full Cash Flow StatementMargins
Gross margin is 52.40%, with operating and profit margins of -16.62% and -11.16%.
| Gross Margin | 52.40% |
| Operating Margin | -16.62% |
| Pretax Margin | -11.16% |
| Profit Margin | -11.16% |
| EBITDA Margin | -9.34% |
| EBIT Margin | -10.39% |
| FCF Margin | -19.08% |
